Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
This security has been delisted
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Juno Therapeutics Inc. buy sebbo

Start price
€44.34
03.07.15 / 50%
Target price
€54.12
04.01.16
Performance (%)
-16.86%
End price
€36.86
04.01.16
Summary
This prediction ended on 04.01.16 with a price of €36.86. The price of Juno Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.86%. sebbo has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Juno Therapeutics Inc. - - - -
iShares Core DAX® -0,87 % 5,32 % 6,86 % 65,21 %
iShares Nasdaq 100 -0,38 % 1,98 % 25,70 % 90,33 %
iShares Nikkei 225® -1,68 % 1,95 % 41,44 % 80,62 %
iShares S&P 500 -0,65 % 2,07 % 21,40 % 70,74 %

Comments by sebbo for this prediction

In the thread Juno Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -16.86%
Target price 54.120
Change
Ends at 04.01.16

MIT überzeugt

Juno Therapeutics ist neulich vom MIT als einer der schlausten Unternehmen der Welt gekührt worden. Es geht hierbei um nicht viel weniger als neue Behandlungswege gegen Krebs.

Ich empfehle daher, ein Auge auf diese Aktie zu werfen.

Prediction Buy
Perf. (%) -16.86%
Target price 54.120
Change
Ends at 04.01.16

(Laufzeit überschritten)